KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma

References

• Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3(1):17009. doi:10.1038/nrdp.2017.9
   PubMed Web of Science ®Google Scholar
• Barata PC, Rini BI. Treatment of renal cell carcinoma: current status and future directions. CA Cancer J Clin. 2017;67:507–524. doi:10.3322/caac.21411
   PubMed Web of Science ®Google Scholar
• Vera-Badillo FE, Templeton AJ, Duran I, et al. Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis. Eur Urol. 2015;67:740–749. doi:10.1016/j.eururo.2014.05.010
   PubMed Web of Science ®Google Scholar
• Fernández-Pello S, Hofmann F, Tahbaz R, et al. A systematic review and meta-analysis comparing the effectiveness and adverse effects of different systemic treatments for non-clear cell renal cell carcinoma. Eur Urol. 2017;71:426–436. doi:10.1016/j.eururo.2016.11.020
   PubMed Web of Science ®Google Scholar
• Chen W, Hill H, Christie A, et al. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature. 2016;539(7627):112–117. doi:10.1038/nature19796
   PubMed Web of Science ®Google Scholar
• Galandra C, Cerami C, Santi GC, et al. Job loss and health threatening events modulate risk-taking behaviours in the Covid-19 emergency. Sci Rep. 2020;10(1):22236. doi:10.1038/s41598-020-78992-x
   PubMed Web of Science ®Google Scholar
• Ning W, Lei S. Open resource of clinical data from patients with pneumonia for the prediction of COVID-19 outcomes via deep learning. Nature Biomedical Engineering. 2020;4:1197–1207. doi:10.1038/s41551-020-00633-5
   PubMed Web of Science ®Google Scholar
• Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus. Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi:10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol Res. 2020;157:104833. doi:10.1016/j.phrs.2020.104833
   PubMed Web of Science ®Google Scholar
• Hamming I, Cooper ME, Haagmans BL, et al. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212(1):1–11. doi:10.1002/path.2162
   PubMed Web of Science ®Google Scholar
• Sobczuk P, Szczylik C, Porta C, Czarnecka AM. Renin angiotensin system deregulation as renal cancer risk factor. Oncol Lett. 2017;14:5059–5068. doi:10.3892/ol.2017.6826
   PubMed Web of Science ®Google Scholar
• Larrinaga G, Pérez I, Sanz B, et al. Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors. Regul Pept. 2010;165(2–3):218–223. doi:10.1016/j.regpep.2010.07.170
   PubMedGoogle Scholar
• Mihalopoulos M, Dogra N, Mohamed N, Badani K, Kyprianou N. COVID-19 and kidney disease: molecular determinants and clinical implications in renal cancer. Eur Urol Focus. 2020;6(5):1086–1096. doi:10.1016/j.euf.2020.06.002
   PubMedGoogle Scholar
• Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459–468. doi:10.1038/s41586-020-2286-9
   PubMed Web of Science ®Google Scholar
• Banerjee AK, Blanco MR, Bruce EA, et al. SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell. 2020;183:1325–39.e21. doi:10.1016/j.cell.2020.10.004
   PubMed Web of Science ®Google Scholar
• Zhan W, Han T, Zhang C, et al. TRIM59 promotes the proliferation and migration of non-small cell lung cancer cells by upregulating cell cycle related proteins. PLoS One. 2015;10(11):e0142596. doi:10.1371/journal.pone.0142596
   PubMed Web of Science ®Google Scholar
• Hu YW, Kang CM, Zhao JJ, et al. LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1. Journal of Cellular and Molecular Medicine. 2018;22(1):497–510. doi:10.1111/jcmm.13338
   PubMed Web of Science ®Google Scholar
• Shi XM, Zhao W, Yang YB, Lü BN. Expression of LOX in colorectal cancer tissues and its relationship with progress and prognosis. J Sichuan Univ Med Sci. 2017;48:566–569.
   Google Scholar
• Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemporary Oncol. 2015;19:A68–77. doi:10.5114/wo.2014.47136
   Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140. doi:10.1093/bioinformatics/btp616
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, Chang M. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Int J Med. 2019;10:1523.
   Google Scholar
• Peña-Llopis S, Brugarolas J. Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications. Nat Protoc. 2013;8(11):2240–2255. doi:10.1038/nprot.2013.141
   PubMed Web of Science ®Google Scholar
• von Roemeling CA, Radisky DC, Marlow LA, et al. Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4. Cancer Res. 2014;74(17):4796–4810. doi:10.1158/0008-5472.CAN-14-0210
   PubMed Web of Science ®Google Scholar
• Wotschofsky Z, Gummlich L, Liep J, et al. Integrated microRNA and mRNA signature associated with the transition from the locally confined to the metastasized clear cell renal cell carcinoma exemplified by miR-146-5p. PLoS One. 2016;11(2):e0148746. doi:10.1371/journal.pone.0148746
   PubMed Web of Science ®Google Scholar
• Liep J, Kilic E, Meyer HA, Busch J, Jung K, Rabien A. Cooperative effect of miR-141-3p and miR-145-5p in the regulation of targets in clear cell renal cell carcinoma. PLoS One. 2016;11(6):e0157801. doi:10.1371/journal.pone.0157801
   PubMed Web of Science ®Google Scholar
• Jones J, Otu H, Spentzos D, et al. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res. 2005;11(16):5730–5739. doi:10.1158/1078-0432.CCR-04-2225
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Science: a Publication of the Protein Society. 2018;27(1):233–244. doi:10.1002/pro.3307
   PubMed Web of Science ®Google Scholar
• Xu S, Xu H, Wang W, et al. The role of collagen in cancer: from bench to bedside. J translational med. 2019;17:309.
   PubMed Web of Science ®Google Scholar
• Walker C, Mojares E. Role of extracellular matrix in development and cancer progression. Int J Mol Sci. 2018;19.
   PubMed Web of Science ®Google Scholar
• Xu X, Jiang C, Wang S, et al. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition. IUBMB Life. 2013;65:873–882. doi:10.1002/iub.1202
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Schneider M, Williamson DB, et al. Two novel protein O-glucosyltransferases that modify sites distinct from POGLUT1 and affect Notch trafficking and signaling. Proc Natl Acad Sci U S A. 2018;115:E8395–e402. doi:10.1073/pnas.1804005115
   PubMed Web of Science ®Google Scholar
• Majumder S, Crabtree JS. Targeting Notch in oncology: the path forward. Nat Rev Drug Discovery. 2020.
   PubMed Web of Science ®Google Scholar
• Schjoldager KT, Narimatsu Y. Global view of human protein glycosylation pathways and functions. Nature Reviews. Molecular Cell Biology. 2020;21(12):729–749. doi:10.1038/s41580-020-00294-x
   PubMed Web of Science ®Google Scholar
• He Q, Yang L, Gao K, et al. FTSJ1 regulates tRNA 2ʹ-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression. Nat Rev Drug Discovery. 2020;11:348.
   Google Scholar
• Dewe JM, Fuller BL, Lentini JM, Kellner SM. TRMT1-catalyzed tRNA modifications are required for redox homeostasis to ensure proper cellular proliferation and oxidative stress survival. The Journal of Pathology. 2017;212:37. doi:10.1128/MCB.00214-17
   Web of Science ®Google Scholar
• Wang B, Wan F, Sheng H, et al. Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis. Sci Rep. 2018;8(1):374. doi:10.1038/s41598-017-18773-1
   PubMed Web of Science ®Google Scholar
• Zerdes I, Matikas A, Bergh J, Rassidakis GZ, Foukakis T. Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations. Oncogene. 2018;37:4639–4661. doi:10.1038/s41388-018-0303-3
   PubMed Web of Science ®Google Scholar
• Chevrier S, Levine JH, Zanotelli VRT, et al. An immune atlas of clear cell renal cell carcinoma. Cell. 2017;169:736–49.e18. doi:10.1016/j.cell.2017.04.016
   PubMed Web of Science ®Google Scholar
• Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell. 2019;179:964–83.e31.
   PubMed Web of Science ®Google Scholar